Here we use a model RGD-containing ligand to study how Ca 2؉ ; 2) it is allosteric to the ligand binding site; 3) its occupation increases the dissociation rate between integrin and RGD ligand; and 4) occupation of the I site can induce cellular deadhesion.
Integrins are ␣␤ heterodimers that mediate cell adhesion to the extracellular matrix (1, 2) . The subjects of this study are two integrins containing the ␤3 subunit, ␣v␤3 and ␣IIb␤3. These two integrins bind the Arg-Gly-Asp (RGD) motif, and both are associated with several significant tissue remodeling events. The platelet integrin ␣IIb␤3 mediates platelet aggregation and also platelet adhesion to the subendothelial matrix (3, 4) . Since platelets are a major constituent of thrombi, ␣IIb␤3 is thought to play a causal role in myocardial infarction, stroke, and atherogenesis. The ␣v␤3 integrin is expressed on osteoclasts, tumor cells, and angiogenic endothelial cells. On osteoclasts, ␣v␤3 directs adhesion to the bone matrix and thus initiates bone resorption (5, 6) . The expression of ␣v␤3 on tumors is associated with their metastatic potential presumably because ␣v␤3 can mediate cell migration on numerous extracellular matrix proteins. The ␣v␤3 integrin is also apparently required for angiogenesis, and it has been postulated that inhibitors of this integrin could prevent tumor growth by interfering with tumor vascularization (7, 8) .
Extracellular divalent cations regulate integrin function by controlling the integrin ligand binding event. The integrins contain three different types of structural motifs that can bind divalent ions. The first type is homologous to the EF-hand Ca 2ϩ binding motifs (9) . There are three or four EF-handlike sites contained within the integrin ␣ subunits (1, 10) . A second metal binding motif, called an A domain is present only in selected integrin ␣ subunits. This domain is about 200 residues in length and has considerable homology to an analogous domain in von Willebrand's factor (11) . The recent crystallization of the A domains of two integrins, Mac-1 and LFA-1, showed that this protein module contains a divalent ion (Mg 2ϩ or Mn 2ϩ ) bound at the apex of a dinucleotide binding motif (12, 13) . The third type of cation binding motif is present within the amino terminus of the integrin ␤ subunits. This site, originally identified by Loftus et al. (14) , is essential for ligand recognition and was thought to be a modified EF-hand motif. However, it is now thought that the ␤ subunit cation binding site is similar to the metal-binding A domain in both ␣M and ␣L (12, 13) .
Although each of these structural motifs is known to bind ions, it is not clear how all of the sites coordinate to regulate the ligand binding event. It must be emphasized that ions can have opposing effects on ligand binding to integrins. Divalent ions are certainly required for ligand binding, but in many cases Ca 2ϩ has been shown to inhibit both ligand binding and cell adhesion (15) (16) (17) . Consequently, a current challenge is to understand the distinction between the cation binding sites that promote ligand binding and those that interfere with ligand binding. Three prior reports have addressed the mechanism by which Ca 2ϩ interferes with integrin function. Staatz et al. (16) showed that Ca 2ϩ is a noncompetitive inhibitor of Mg 2ϩ -supported collagen binding to the ␣2␤1 integrin, providing initial kinetic evidence that Ca 2ϩ and Mg 2ϩ could bind to different classes of sites on integrin. A second report by Mould et al. (18) also indicated the presence of functionally distinct ion binding sites, one of which promotes ligand binding and another that can suppress ligand binding. A study from this laboratory attempted to address the mechanism of cation regulation by measuring kinetic constants for the binding of natural adhesive proteins to the two ␤3-integrins (19) . Because the binding between natural adhesive proteins and the ␤3-integrins rapidly becomes nondissociable (20, 21) , we were only able to define the "apparent" association rate constant (k 1app ) between ligands and integrin. This rate constant is useful in that it describes the rate at which ligands become stably bound to integrin, but it is really a product of three rate constants, k 1 , k Ϫ1 , and k 2 (21) . Therefore, measuring k 1app did not allow us to discern the fine kinetic detail of how divalent ions regulate ligand association and dissociation rates.
In this report we advance substantially the kinetic model of * This work was supported by National Institutes of Health Grants CA 56483 and AR 42750 (to J. W. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported initially by a postdoctoral grant from Monsanto/Searle and subsequently by a postdoctoral grant from the California Affiliate of the American Heart Association.
ʈ A Scholar of the American Foundation for AIDS Research and the recipient of an Investigator Award from the Cancer Research Institute. ** An Established Investigator of the American Heart Association under the sponsorship of Genentech. To whom correspondence shouldhow cations regulate ligand binding to both ␣v␤3 and ␣IIb␤3 by using a model antibody ligand called Fab-9. This antibody was derived from a human antibody directed against human immunodeficiency virus gp120 (22) . However, Fab-9 was engineered to contain an optimized integrin-binding RGD motif in the antigen binding site. Fab-9 was then optimized by phage display to have high affinity for both ␣v␤3 and ␣IIb␤3 (23, 24) . Unlike natural adhesive proteins, which bind to integrin nondissociably, Fab-9 binds to integrin in a reversible manner. This is presumably because Fab-9 is monomeric and also because it presents only a single contact point for integrin, the RGD-containing loop in heavy chain complementarity determining region 3. The unique features of Fab-9 and the application of surface plasmon resonance to measure binding in real time allowed us to measure the effects of divalent cations on the individual kinetic constants between Fab-9 and integrin. A key assumption in this study is that Fab-9 does not bind divalent ions. We believe this to be reasonable because the antibody from which Fab-9 was engineered binds to its ligand (human immunodeficiency virus gp120) in a cation-independent manner (22) . In the current study, we measured the effects of both Ca 2ϩ and Mg 2ϩ on the binding of Fab-9 to both ␤3-integrins. In summary, this study reveals that there are two classes of cation binding sites on the two ␤3-containing integrins. The first class of sites promote ligand binding to integrin when occupied by divalent cations. The second class of sites are allosteric to the ligand binding site, are highly specific for Ca 2ϩ , and when occupied, increase the dissociation rate between RGD and integrin. To our knowledge this is the first evidence showing that divalent cations regulate the dissociation rate for RGD ligand.
MATERIALS AND METHODS
Proteins-Integrin ␣v␤3 was purified from an octylglucoside extract of human placenta by monoclonal antibody affinity chromatography (25) . Integrin ␣IIb␤3 was purified from human platelets by affinity chromatography on KYGRGDS-Sepharose (26) . Fab-9 was generated from a combinatorial phage library as described previously (23, 24) . Fab-9 was affinity-purified from bacterial lysate by antibody affinity chromatography using goat anti-human IgG-Sepharose. Fab-9 was radiolabeled with 125 I using IODO-GEN (Pierce). Typical specific activities were between 3 and 5 ϫ 10 4 cpm/ng. Cell Lines-Human embryonic kidney carcinoma 293 cells were obtained from ATCC. The 293 cells were transfected with the cDNA encoding the integrin ␤3 subunit in the pcDNA3 expression vector using DOTAP transfection reagent (Boehringer Mannheim). Stable transfectants were obtained by fluorescence-activated cell sorting after selection in 500 g/ml G418 (Sigma). Cells were maintained in Dulbecco's modified Eagle's medium (BioWhittaker, Inc.) supplemented with 10% fetal calf serum (Irvine Scientific), 20 mM Hepes (pH 7.4), 1% glutamine, 1% penicillin, and 1% streptomycin (Sigmas).
Ligand Binding Assays-The binding of Fab-9 to integrins was measured using a ligand binding assay that has been previously described (19) . To study ligand binding as a function of cations, the type and concentration of divalent cation were varied, and 125 I-Fab-9 was used at a fixed concentration, 0.5 nM. To ensure that the immobilized integrin did not contain endogenously bound cation, the plate was briefly treated with EDTA. The plate was then washed six times with cation-free binding buffer (50 mM Tris, 100 mM NaCl, and 1 mg/ml bovine serum albumin, pH 7.4). Because the ␣IIb␤3 integrin cannot withstand exposure to EDTA, this integrin was washed six times with cation-free binding buffer to remove endogenously bound ions.
125 I-Fab-9 was allowed to bind to integrin for 3 h at 37°C, at which time the binding had reached equilibrium. To measure the ability of cations to dissociate ligand from integrin, 125 I-Fab-9 was allowed to bind integrin under the optimal cation conditions (0.05 mM Mn 2ϩ for ␣v␤3 or 0.05 mM Ca 2ϩ for ␣IIb␤3) for 3 h at 37°C. Then free ligand was removed by washing, and a dissociation solution containing the binding buffer and the desired cation(s) was added to the microtiter wells. Ligand dissociation was allowed to proceed for 90 min at 37°C. The amount of ligand remaining bound was determined by ␥-counting as described previously (19) . In all cases, nonspecific binding was measured in the presence of 20 mM EDTA and was subtracted from the total binding to yield specific binding. The data from these measurements were highly reproducible, with the differences between data points typically below 7%. Results are expressed as the average of triplicate data points, and all experiments were repeated at least three times.
Cell Adhesion Assays-Cell adhesion was measured using previously described methods (17) . Purified Fab-9 was coated on to 96-well microtiter plates (Titertek) and incubated overnight at 4°C. The plates were then blocked with 20 mg/ml of bovine serum albumin in binding buffer for 1 h at 37°C. Cells were harvested from tissue culture flasks with phosphate-buffered saline/EDTA, washed and resuspended in adhesion buffer (1 ϫ Hanks' balanced salt solution, 50 mM Hepes (pH 7.4), 1 mg/ml bovine serum albumin) containing either Ca 2ϩ or Mg 2ϩ at the specified concentrations. In most experiments 100 l of cells (1.5 ϫ 10 6 cells/ml) were added to each well. Nonspecific adhesion was measured in the presence of 20 mM EDTA. After a 45-min incubation at 37°C, the nonadherent cells were removed by gentle aspiration. Adherent cells were detected using a colorimetric assay for lysosomal acid phosphatase activity with a chromophore that absorbs at 405 nm (27) . A standard curve with cells in suspension showed that absorbance values were directly proportional to cell number. All experiments were performed at least three times, yielding identical results.
Surface Plasmon Resonance-The kinetic parameters (association and dissociation rate constants, k 1 and k Ϫ1 , respectively) and the affinity constant (K d ) between Fab-9 and integrins were measured by the surface plasmon resonance using BIAcore TM (Pharmacia Biotech Inc.). The application of surface plasmon resonance to measure kinetic constants for integrins has been described previously (17, 24) . Briefly, integrin was coupled to the biosensor chip with the amine coupling kit. Ligand solution was applied to the sensor chip, and the binding was measured as a function of time. Both association and dissociation reactions were performed in Tris-buffered saline (50 mM Tris, 100 mM NaCl, pH 7.4) containing specified cations. These measurements yielded rate constants, k 1 and k Ϫ1 . The overall affinity constant, K d , was derived from k Ϫ1 /k 1 . To study ligand dissociation as a function of cations, the initial binding reaction was performed in buffer containing 0.2 mM Mn 2ϩ , and then the buffer was changed to Tris-buffered saline containing either Ca 2ϩ or Mg 2ϩ at the specified concentrations. The ionic strength of the buffer was maintained at a constant level by adjusting the amount of NaCl. . Binding was measured at equilibrium. In Mg 2ϩ the binding of 125 I-Fab-9 to ␣v␤3 exhibits a "normal" isotherm, with the binding reaching saturation at 1-2 mM Mg 2ϩ (Fig. 1A) . A biphasic binding isotherm was observed across the same range of Ca 2ϩ . In this cation, the binding of Fab-9 to ␣v␤3 increased with ion concentration, but at 0.1 mM Ca 2ϩ the binding dissipated. At 5 mM Ca 2ϩ very little specific binding of Fab-9 to ␣v␤3 was detected. This result indicates the existence of two classes of Ca 2ϩ binding sites on the integrin. Occupation of the first class of sites with low concentrations of Ca 2ϩ (less than 0.1 mM) promotes Fab-9 binding to integrin. At higher levels of Ca 2ϩ (greater than 0.1 mM), the second class of sites are occupied, and ligand binding is inhibited. Thus, we call the second class of inhibitory or I sites. Identical results were obtained with the ␣IIb␤3 integrin (not shown). Using the same procedure, we also measured the binding between ␤3-integrins and several other RGD-containing antibodies obtained from phage libraries (24) . In each case, a biphasic binding profile was observed as a function of Ca 2ϩ concentration. Thus, the inhibition of ligand binding by Ca 2ϩ appears to be a property common to ligands that present only a single RGD contact point.
RESULTS

Divalent Cations Differentially Regulate Fab-9 Binding to
The effects of different cation conditions on cell adhesion to immobilized Fab-9 were also measured. Kidney 293 cells expressing the ␣v␤3 heterodimer were allowed to adhere to Fab-9 across a concentration range of divalent ion (Fig. 1B) Fig. 2A) but did not affect the absolute amount of Fab-9 bound at saturation (B max ). A transformation of the data in Fig. 2A into a Dixon plot yielded a series of lines intersecting to the left of the y axis and above the origin (Fig.  2B) . Nearly identical results were obtained with integrin ␣IIb␤3 (data not shown). These data prove that Ca 2ϩ is a competitive inhibitor of Fab-9 binding to integrin, i.e. the binding of Ca 2ϩ to the I site and binding of Fab-9 to integrin are mutually exclusive.
Ca 2ϩ Induces the Dissociation of Fab-9 from Integrins-The studies shown in Fig. 2 were performed under equilibrium conditions where ligand and a divalent cation were incubated with integrin simultaneously. To determine if divalent ions could induce the dissociation of Fab-9 that had already bound to integrin, two types of experiments were performed. In the first experiment, 125 I-Fab-9 was allowed to bind to purified integrin immobilized in a microtiter plate. This binding step was allowed to proceed to equilibrium. Then free 125 I-Fab-9 was removed by washing, and different levels of Ca 2ϩ or Mg 2ϩ were introduced in an attempt to dissociate Fab-9. Following a 90-min incubation at 37°C, the amount of 125 I-Fab-9 remaining bound to integrin was measured by ␥-counting. As shown in Fig. 3, A and B, Mg 2ϩ did not induce significant dissociation of Fab-9 from either ␣v␤3 or ␣IIb␤3. In contrast, Ca 2ϩ promoted dissociation of Fab-9 from both integrins. Between 1 and 2 mM can induce the dissociation of Fab-9 from integrin. Because the readout from these studies was taken following a 90-min incubation with the ion (at steady state), Fab-9 could potentially dissociate and rebind during the second part of the assay. Consequently, the possibility remained that Ca 2ϩ acted by preventing rebinding of Fab-9 to integrin. To distinguish between these possibilities and to quantify the effect of cations on the dissociation of Fab-9 from integrin, surface plasmon resonance measurements were made (Fig. 3, C and D) . Plasmon resonance monitors a binding reaction in real time and can provide ligand association and dissociation constants separately. We sought to determine the effects of ions on ligand dissociation rate, which is described by the rate constant (k Ϫ1 ). After allowing binding between Fab-9 and integrin to reach equilibrium in 0.2 mM Mn 2ϩ , the buffer was changed to a dissociation buffer containing either 5 mM Ca 2ϩ or 5 mM Mg 2ϩ (Fig. 3, C and D, double hash mark) . Ca 2ϩ caused the rapid dissociation of Fab-9 from both ␣v␤3 (k Ϫ1 ϭ 2.7 ϫ 10 Ϫ3 s
Ϫ1
) and . We also measured the changes in ligand association rate across the range of Ca 2ϩ that inhibits ligand binding. Across this range, the association rate constant between Fab-9 and ␣v␤3 was not significantly affected (Table I) . However, the dissociation rate constant between Fab-9 and integrin increased 12-15-fold. Ca 2ϩ also increased the dissociation rate between Fab-9 and ␣IIb␤3 across the same range of ion (not shown). 
An Inhibitory Ca 2ϩ Binding Site on ␤3-Integrins
Hence, across this range, Ca 2ϩ influences only the ligand dissociation rate. This finding implies that Ca 2ϩ is a nonclassical competitive inhibitor of Fab-9 binding to integrin and that Ca 2ϩ and Fab-9 bind to separate sites (see "Discussion"). The effects of Ca 2ϩ can be distinguished from those of a "pure" competitive inhibitor of ligand binding. For example, the RGD analog SC 52012 (28), which is a competitive inhibitor of ligand binding to integrin ␣ IIb ␤ 3 (not shown), does not influence the dissociation rate between Fab-9 and the integrin. Even 50 M SC 52012, a level of compound that is nearly 1000-fold above its K d for the integrin, had no effect on the dissociation rate constant between Fab-9 and integrin (6.1 ϫ 10 Ϫ4 s Ϫ1 versus 6.9 ϫ 10 Ϫ4 s
Ϫ1
). Thus, both Ca 2ϩ and the RGD analog competitively inhibit Fab-9 binding to integrin, but they do so by different mechanisms.
The I Site is Specific for Ca 2ϩ
-Fab-9 bound to both ␤3-integrins across a wide range of Mg 2ϩ concentration (Fig. 1A) . More importantly, Mg 2ϩ failed to dissociate Fab-9 from either integrin (Fig. 3, A and B) . It is possible that Mg 2ϩ does not bind the I site or that Mg 2ϩ binds the I site but fails to induce the dissociation of Fab-9. We reasoned that if Mg 2ϩ binds the I site without increasing ligand dissociation, then it should compete with Ca 2ϩ and protect the ligand-receptor complex from dissociation. This possibility was tested by attempting to block the Ca . These data indicate that Mg 2ϩ is unable to compete with Ca 2ϩ for binding to the I site. We conclude that the I site is a calcium-specific inhibitory site. Ca 2ϩ Can Induce Cellular Deadhesion-Studies were conducted to determine whether occupation of the I site by Ca 2ϩ could initiate cellular deadhesion. Kidney 293 cells expressing ␣v␤3 were allowed to adhere to immobilized Fab-9 in the presence of 0.2 mM Mn 2ϩ (Fig. 5A) , an optimal condition for cell adhesion through integrin ␣v␤3. Then the buffer was changed to contain either 2 mM Ca 2ϩ or 2 mM Mg Data were collected by surface plasmon resonance at room temperature. Fab-9 in buffer containing a series of concentrations of Ca 2ϩ or Mg 2ϩ (not shown) was injected to biosensor chip coated with ␣v␤3. Both association and dissociation rate constants were measured, and the binding constant K d was derived from k I/ k I . Our results show that Ca 2ϩ reduces the overall affinity (K d ) but not B max of integrin for Fab-9 (Fig. 2) . Therefore, Ca 2ϩ is a competitive inhibitor of ligand binding. More importantly, real time binding studies show that Ca 2ϩ increases only the ligand dissociation rate. The overall affinity for ligand (K d ) is a product of the ligand association rate (k 1 ) and dissociation rate (k Ϫ1 ). Calcium ion decreases the overall affinity by increasing k Ϫ1 , suggesting that Ca 2ϩ is a nonclassical inhibitor. In "pure competitive inhibition" the two competing ligands bind to a common binding site (Fig. 6A) . In this case one would expect the competitor to change the affinity for ligand by influencing the ligand association rate. However, the behavior of Ca 2ϩ is more consistent with the model shown in Fig. 6B , where the ligand binding site and the I site are distinct. The fact that Ca 2ϩ can induce dissociation of preformed complexes between Fab-9 and integrin, in which the RGD binding site is occupied, also support the idea that the ion and ligand bind to separate -induced dissociation of Fab-9 from integrin was tested using the purified ligand-receptor binding assay.
125 I-Fab-9 was allowed to bind to purified integrin ␣v␤3 in Mn 
An Inhibitory Ca
2ϩ Binding Site on ␤3-Integrinssites. Consequently, the simplest interpretation of these data is that the I site and the RGD binding site are distinct and that the I site regulates the ligand off-rate by allostery. We cannot exclude the possibility that the I site and the RGD binding site may share some contact points; however, the data indicate that the I site remains capable of binding to Ca 2ϩ even when ligand is bound to the integrin.
The apparent K d of the I site for Ca 2ϩ is between 1 and 2 mM (Fig. 2A, Table I ), so under physiologic conditions this site is probably occupied. How then, does occupation of the I site influence the binding of natural ligands to integrins? To address this issue, consideration must be given to the differences in the way that natural ligands and Fab-9 bind to integrins. The natural ligands have multiple contact points for integrin that presumably stabilize the integrin-ligand complex so that it is essentially nondissociable (20) . Current thinking is that the RGD motif mediates initial contact and that ancillary contacts create a nondissociable integrin-ligand complex (32) . This binding reaction has been previously described kinetically by Reaction 1 (21), a two-step reaction leading to a stabilized integrinligand complex,
where L represents ligand and R represents integrin. The ligand and integrin initially form a reversible ligand-integrin complex (LR). The second step in this reaction, described by the constant k 2 , leads to an irreversible complex between ligand and integrin. It is important to emphasize that k 2 Ͼ Ͼ k 1 (19, 21) ; therefore, the rate of the forward reaction predominates, and the stabilized complex is the only species that can be detected using conventional binding studies. In contrast to the natural ligands, Fab-9 binds to integrins in a simple and reversible manner that can be described by Reaction 2.
Thus, the binding of Fab-9 is not stabilized by a secondary binding step, and there is not a kinetic constant (k 2 ) to complicate the kinetic analysis.
These differences may explain why ions do not always regulate the binding of natural ligands in this same way that they regulate the binding of Fab-9. In fact, there are even substantial differences in the way that cations appear to regulate the binding of natural ligands. Ligands like vitronectin and fibronectin bind to ␣v␤3 even when Ca 2ϩ is present at millimolar concentrations (19) , indicating that the Ca 2ϩ -binding site (the I site) does not prohibit their binding to integrin. One explanation for the ability of these two proteins to bind integrin ␣v␤3 even in the presence of Ca 2ϩ is that ligand and Ca 2ϩ bind in a mutually exclusive manner. Thus, vitronectin and fibronectin may exclude Ca 2ϩ from the I site. Other ligands like fibrinogen and osteopontin cannot bind to ␣v␤3 when Ca 2ϩ is present (17, 19) , suggesting that the binding of these proteins is blocked by Ca 2ϩ binding to the I site. We suggest that Ca 2ϩ occupation of the I site in these equilibrium reactions increases the dissociation rate to the point where it is much faster than the association rate. Therefore, the binding of these proteins to ␣v␤3 cannot be measured using the current approaches. Other methods, like stopped-flow technology, may be required to measure these kinetic parameters. We also measured the ability of Ca 2ϩ to induce the dissociation of these ligands when they were prebound to ␣v␤3. We did not observe the induced dissociation of any natural ligands by Ca 2ϩ (not shown). Therefore, the stabilization of ligand binding, described by the constant k 2 (Reaction 1), appears to prevent the action of Ca 2ϩ at the I site. In fact, it seems reasonable to speculate that the function of the I site could be lost as a consequence of the stabilized, or nondissociable ligand binding.
Extracellular Ca 2ϩ regulates the adhesion and morphology of osteoclasts. This observation has been taken to indicate that osteoclasts contain a Ca 2ϩ receptor that regulates adhesion (33, 34) . We have previously suggested that the ␣v␤3 integrin may be the osteoclast Ca 2ϩ receptor (17) . One potential function of the I site may be to regulate cellular deadhesion. As shown in Fig. 5 , Ca 2ϩ can induce the rounding up of adherent cells. This may be relevant in situations like bone resorption, where the osteoclast rounds up from the bone surface after resorption is completed. The identification of the I site on ␣v␤3 provides a mechanism by which Ca 2ϩ could induce cellular deadhesion by acting directly on the integrin. One of the limitations in providing an absolute proof of this hypothesis is that natural ligands bind to purified integrin in a nondissociable manner (see above). Therefore, it is difficult to extrapolate directly from binding studies with purified protein to the conditions that exist on the cell surface. Despite the above difference, we have observed instances on whole cells, where the I site may still regulate integrin function. For example, on cells adherent to vitronectin, integrin ␣v␤3 clusters into focal contacts when Mg 2ϩ is present but fails to assemble in focal contacts when Ca 2ϩ is present. In fact, Ca 2ϩ can induce the dissociation of the integrin from organized focal contacts (35) . In conjunction with the data presented here, it is tempting to speculate that the allosteric cation binding site regulates cell surface organization or clustering of integrins. This hypothesis is currently under investigation.
We recently put forth a "displacement hypothesis" that may explain much of the regulation of ligand binding to integrins by divalent cations (31) . We found that just as divalent ions can regulate ligand binding affinity, ligand can also regulate divalent cation binding affinity. Specifically, we found that the addition of RGD ligand to the ␣IIb␤3 integrin could "displace" the binding of two of three bound Mn 2ϩ ions. We interpreted this result to imply that ligand and divalent cation may actually compete for the same binding site on integrin. The findings in the current study provide support for the displacement hypothesis but also suggest some important modifications. The data presented here show that the binding of ligand to its site and the binding of ion to the I site are mutually exclusive. Yet, the inhibition of ligand binding by ion occupation of the I site is not "purely" competitive. In fact, a major finding of this report is that the I site is allosteric or is physically distinct from the ligand binding site. Presumably, Ca 2ϩ binding to the I site induces a conformational change in the ligand binding site that favors ligand dissociation. Thus, the results from this study indicate that ligand and the displaced divalent cation do not necessarily bind to the same site on integrin as was implied (31) . Consequently, we conclude that the ligand binding site and the inhibitory Ca -binding site as a rational target for inhibitors of integrin function. Antagonists that bind to this site and increase the dissociation rate for ligand may be expected to have pharmacological properties different from compounds that interact with the ligand binding pocket.
